Integrin blocking peptide reverses immunosuppression in experimental gliomas and improves anti-PD-1 therapy outcome
Aleksandra Ellert‐Miklaszewska, Paulina Pilanc, Katarzyna Poleszak, Adrià-Jaume Roura, Salwador Cyranowski, Mitrajit Ghosh, Szymon Baluszek, Maria Pasierbińska, Bartłomiej Gielniewski, Julian Swatler, Yuliana Hovorova, Kamil Wojnicki, Bozena Kaminska
This study shows that an integrin-blocking peptide enhances anti-PD-1 therapy in gliomas by reversing immunosuppression and restoring an inflammatory tumor microenvironment.
bioRxiv · Aug 6, 2024 · PreprintCancer Biology